10 results
8-K
EX-99.2
BTTX
Better Therapeutics Inc
9 Dec 22
Better Therapeutics Completes Exploratory Trial for Fatty Liver Disease and Announces Positive Topline Results
6:56pm
% % Hispanic/Latino 41% Body Mass Index (mean) 38 kg/m2 Liver Disease Diagnosis at Baseline NASH 77% NAFLD 23% Baseline Liver Fat (mean MRI-PDFF %) 19
424B3
BTTX
Better Therapeutics Inc
28 Jul 22
Prospectus supplement
8:59am
% Asian 5.2% 5.2% American Indian or Alaskan Native 1.7% 1.2% Native Hawaiian or Other Pacific Islander 0.6 0.3% Ethnicity - Hispanic or Latino % 14.0
8-K
EX-99.2
BTTX
Better Therapeutics Inc
28 Jul 22
Better Therapeutics Completes Pivotal Trial of BT-001 for Type 2 Diabetes
8:56am
or Alaskan Native 1.7% 1.2% Native Hawaiian or Other Pacific Islander 0.6 0.3% Ethnicity - Hispanic or Latino % 14.0% 17.2% $67,737 Median Household
DEF 14A
BTTX
Better Therapeutics Inc
27 Apr 22
Definitive proxy
12:37pm
: Gender Identity
Directors
Part 2: Demographic Background
African American or Black
Alaskan Native or Native American
Asian
Hispanic or Latinx
Native
424B3
biehob vhwtnao20w3
15 Mar 22
Prospectus supplement
5:15pm
8-K/A
EX-99.1
q95wb3maa
15 Mar 22
Other Events
5:08pm
424B3
fuqmhsa kpzic0nj5
15 Mar 22
Prospectus supplement
7:37am
8-K
EX-99.2
blezs6pq
15 Mar 22
Other Events
7:17am
8-K
EX-99.1
b0f7 aarn
15 Mar 22
Other Events
7:17am
- Prev
- 1
- Next